Management of seasonal allergic conjuctivitis (SAC): current therapeutic strategies

被引：13

作者：

Anderson, DF ^{[1
]}

机构：

[1] Univ Southampton, Eye Unit, Southampton S016 6YD, Hants, England

来源：

CLINICAL AND EXPERIMENTAL ALLERGY | 2001年 / 31卷 / 06期

关键词：

D O I：

10.1046/j.1365-2222.2001.01148.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：823 / 826

页数：4

共 34 条

[1]

ABELSON MB, 1981, ARCH OPHTHALMOL-CHIC, V99, P302

[2] Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration [J].

Anderson, DF ;

MacLeod, JDA ;

Baddeley, SM ;

Bacon, AS ;

McGill, JI ;

Holgate, ST ;

Roche, WR .

CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 (09) :1060-1066

[3]

Anderson DF, 2001, INVEST OPHTH VIS SCI, V42, P995

[4]

Bacon AS, 1998, INVEST OPHTH VIS SCI, V39, P322

[5] CLINICAL-EVALUATION OF KETOROLAC TROMETHAMINE 0.5-PERCENT OPHTHALMIC SOLUTION FOR THE TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS [J].

BALLAS, Z ;

BLUMENTHAL, M ;

TINKELMAN, DG ;

KRIZ, R ;

RUPP, G .

SURVEY OF OPHTHALMOLOGY, 1993, 38 :141-148

[6] FAILURE OF PUTATIVE IGE PENTAPEPTIDE TO COMPETE WITH IGE FOR RECEPTORS ON BASOPHILS AND MAST-CELLS [J].

BENNICH, H ;

RAGNARSSON, U ;

JOHANSSON, SGO ;

ISHIZAKA, K ;

ISHIZAKA, T ;

LEVY, DA ;

LICHTENSTEIN, LM .

INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1977, 53 (05) :459-468

[7] Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis [J].

Bonini, S ;

Schiavone, M ;

Bonini, S ;

Magrini, L ;

Lischetti, P ;

Lambiase, A ;

Bucci, MG .

OPHTHALMOLOGY, 1997, 104 (05) :849-853

[8] INTERLEUKIN-4 IS LOCALIZED TO AND RELEASED BY HUMAN MAST-CELLS [J].

BRADDING, P ;

FEATHER, IH ;

HOWARTH, PH ;

MUELLER, R ;

ROBERTS, JA ;

BRITTEN, K ;

BEWS, JPA ;

HUNT, TC ;

OKAYAMA, Y ;

HEUSSER, CH ;

BULLOCK, GR ;

CHURCH, MK ;

HOLGATE, ST .

JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1381-1386

[9] NEDOCROMIL SODIUM - AN UPDATED REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN ASTHMA [J].

BROGDEN, RN ;

SORKIN, EM .

DRUGS, 1993, 45 (05) :693-715

[10] Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro [J].

Buscaglia, S ;

Paolieri, F ;

Catrullo, A ;

Fiorino, N ;

Riccio, AM ;

Pesce, G ;

Montagna, P ;

Bagnasco, M ;

Ciprandi, G ;

Canonica, GW .

CLINICAL AND EXPERIMENTAL ALLERGY, 1996, 26 (10) :1188-1196

← 1 2 3 4 →